Industry News prev next

Jan 27 2022

Sustained IOP Reduction with iDose TR

posted by: Janet Swartz, EdD

Glaukos reports sustained IOP reduction over 36 months from its iDose TR sustained-release travoprost implant. To read the full press release, click on this link: Glaukos Press Release.